Nunzia Pharmaceutical Corporation Stock Other OTC
Equities
NUNZ
US67097W1027
Pharmaceuticals
Sales 2020 | - | Sales 2021 | - | Capitalization | 170M 232M |
---|---|---|---|---|---|
Net income 2020 | -9M -12.3M | Net income 2021 | -78M -107M | EV / Sales 2020 | - |
Net cash position 2020 * | - 0 | Net Debt 2021 | 97.31K 133K | EV / Sales 2021 | - |
P/E ratio 2020 |
-94.8
x | P/E ratio 2021 |
-2.54
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 18.04% |
Managers | Title | Age | Since |
---|---|---|---|
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
President | 68 | 08-12-31 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 19-12-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 68 | 08-12-31 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 19-12-04 |
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
1st Jan change | Capi. | |
---|---|---|
+31.52% | 662B | |
+21.96% | 546B | |
-5.21% | 359B | |
+17.02% | 323B | |
+5.01% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.98% | 167B |